Coagulopathy of the critically ill equine patient: State-of-the-Art-Review

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 1, 2009, Pages 53-65

  Dallap Schaer, Barbara L ^a   Epstein, Kira ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Coagulation testing; Hemostasis; Inflammation

Indexed keywords

ANTICOAGULANT AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD CLOTTING DISORDER; CRITICAL ILLNESS; HORSE; HORSE DISEASE; HUMAN; RISK FACTOR;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; CRITICAL ILLNESS; HORSE DISEASES; HORSES; HUMANS; RISK FACTORS;

EQUIDAE;

EID: 61449122046     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00390.x     Document Type: Article

References (108)

1. Gando S, Kameue T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 1997 25 : 1820 1826.
2. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 1995 74 : 848 852.
3. Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992 101 : 816 823.
4. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999 341 : 586 592.
5. Ikegami K, Suzuki Y, Yukioka T, et al. Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma. J Trauma 1998 44 : 789 794.
6. Lin SM, Wang YM, Lin HC, et al. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis. Crit Care Med 2008 36 : 683 689.
7. Topper MJ, Prasse KW. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic. Am J Vet Res 1996 57 (4) : 456 462.
8. Darien BJ, Pontempa J, Moore JN, et al. Antithrombin III activity in horses with colic: an analysis of 46 cases. Equine Vet J 1991 23 (3) : 211 214.
9. Johnstone IB, Crane S. Haemostatic abnormalities in horses with colic - their prognostic value. Equine vet J 1986 18 (4) : 271 274.
10. Dolente BA, Wilkins PA, Boston RC. Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis. J Am Vet Med Assoc 2002 220 (7) : 1034 1038.
11. Dallap BL, Dolente B, Boston R. Coagulation profiles in 27 horses with large colon volvulus. J Vet Emerg Crit Care 2003 13 (4) : 215 225.
12. Collatos C, Barton MH, Prasse KW, et al. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. J Am Vet Med Assoc 1995 207 (4) : 465 470.
13. Barton MH, Deem Morris D, Norton N, et al. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J Vet Intern Med 1998 12 : 26 35.
14. Cotovio M, Monreal L, Armengou L, et al. Fibrin deposits and organ failure in newborn foals with severe septicemia. J Vet Intern Med 2008 22 : 1403 1410.
15. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000 217 : 1500 1504.
16. Frenette PS, Johnson RC, Hynes RO, et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995 92 : 7450 7454.
17. Thomas S. Platelet membrane glycoproteins in haemostasis. Clin Lab 2002 48 : 247 262.
18. McMichael M. Primary hemostasis. J Vet Emerg Crit Care 2005 15 : 1 8.
19. Ashby B, Colman R, Daniel J, et al. Platelet stimulatory and inhibitory receptors, In : Colman R, Hirsh J, Marder VJ, Clowes AW, George JN. eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia : Lippincott, Williams & Wilkins 2001, pp. 505 520.
20. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003 1 : 1335 1342.
21. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003 101 (10) : 3765 3777.
22. Sugama Y, Tiruppathi C, Offakidevi K, et al. Thrombin-induced expression of endothelial P-selectin and intracellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol 1992 119 : 935 944.
23. Vischer UM, Barh H, Wollheim CB. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler Thromb Vasc Biol 2000 20 : 883 891.
24. Zimmerman GA, McIntyre TM, Prescott SM. Production of platelet-activating factor by human vascular endothelial cells: evidence for requirement for specific agonists and modulation by prostacyclin. Circulation 1985 72 : 718 727.
25. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003 197 : 585 1598.
26. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996 87 : 4651 4663.
27. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998 161 : 4382 4387.
28. Sabatier F, Roux V, Anfosso F, et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002 99 : 3962 3970.
29. Schecter AD, Spirn B, Rossikhina M, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000 87 : 126 132.
30. Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004 104 : 3190 3197.
31. Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Ann Rev Med 1995 46 : 103 112.
32. Roemisch J, Gray E, Hoffmann JN, et al. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coag Fibrinolysis 2002 13 (8) : 657 670.
33. Esmon CT. Protein C, protein S, and thrombomodulin, In : Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia : Lippincott Williams & Wilkins 2001, pp. 335 353.
34. Rezaie AR, Cooper ST, Chrich FC, et al. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995 270 : 25336 25339.
35. Bourin MC, Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem J 1993 289 : 313 330.
36. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001 29 (7, suppl) : S48 S51.
37. Heeb MJ, Gruber A, Griffin JH. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha2-macroglobulin and alpha2-antiplasmin in blood and comparisons to inhibition of factors Xa, thrombin, and plasmin. J Biol Chem 1991 266 : 17606 17612.
38. Aras O, Shet A, Bach R, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004 103 : 4545 4553.
39. Oullette AL, Evans RJ, Heath MF. Platelets enhance endotoxin-induced monocyte tissue factor activity in the horse. Res Vet Sci 2004 76 : 31 35.
40. Glaser CV, Morser J, Clarke JH, et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 1992 90 : 2565 2573.
41. Takano S, Kimura S, Ohdama S, et al. Plasma thrombomodulin in health and disease. Blood 1990 76 : 2024 2029.
42. Conway EM, Rosenber RD. Tumor necrosis factor suppresses transcription of thrombomodulin gene in endothelial cells. Mol Cell Biol 1988 8 : 5588 5592.
43. Mavrommatis AC, Theodoridis T, Economou M, et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 2001 27 : 1853 1859.
44. Nesheim M. Thrombin and fibrinolysis. Chest 2003 124 (3, suppl) : 33S 39S.
45. Dolente B, Beech J, Lindborg S, et al. Evaluation of risk factors for development of catheter-associated jugular thrombophlebitis in horses: 50 cases (1993-1998). J Am Vet Med Assoc 2005 227 : 1334 1341.
46. Brainceau P, Divers TJ. Acute thrombosis of limb arteries in horses with sepsis: five cases (1988-1998). Equine Vet J 2001 33 : 105 109.
47. Breshears MA, Holbrook TC, Haak CE, et al. Pulmonary aspergillosis and ischemic distal limb necrosis associated with enteric salmonellosis in a foal. Vet Pathol 2007 44 : 215 217.
48. Moore LA, Johnson PJ, Baily KL. Aorto-iliac thrombosis in a foal. Vet Res 1998 142 : 459 462.
49. Norman TE, Chaffin MK, Perris EE, et al. Massive pulmonary thromboembolism in six horses. Equine Vet J 2008 40 : 514 517.
50. Carr EA, Carlson GP, Wilson D, et al. Acute hemorrhagic pulmonary infarction and necrotizing pneumonia in horses: 21 cases (1967-1993). J Am Vet Med Assoc 1997 210 : 1774 1778.
51. Ryu SH, Kim JG, Bak UB, et al. A hematogenic pleuropneumonia caused by septic thrombophlebitis in a Thoroughbred gelding. J Vet Sci 2004 5 : 75 77.
52. Lankveld D, Ensink J, Van Kijk P, et al. Factors influencing the occurrence of thrombophlebitis after post-surgical long-term catheterization of colic horses: a study of 38 cases. J Vet Med Assoc 2001 48 : 545 552.
53. Johnstone IB, Crane S. Hemostatic abnormalities in equine colic. Am J Vet Res 1986 47 (2) : 356 358.
54. Henry MM, Moore JN. Whole blood re-calcification time in equine colic. Equine Vet J 1991 23 (4) : 303 308.
55. Henry MM, Moore JN. Clinical significance of monocyte procoagulant activity in horses with colic. J Am Vet Med Assoc 1991 198 (5) : 843 848.
56. Welch RD, Watkins JP, Taylor TS, et al. Disseminated intravascular coagulation associated with colic in 23 horses (1984-1989). J Vet Intern Med 1992 6 (1) : 29 35.
57. Cotovio M, Monreal L, Navarro M, et al. Detection of fibrin depositis in tissues from horses with severe gastrointestinal disorders. J Vet Intern Med 2007 21 : 308 313.
58. Epstein K, Brainard B, Lopes M, et al. Thrombelastography in 26 healthy horses with and without activation by human recombinant tissue factor. J Vet Emerg Crit Care 2009 19 (1) : 96 101.
59. Sandholm M, Vidovic A, Puotunen-Reinert A, et al. D-dimer improves the prognostic value of combined clinical and laboratory data in equine gastrointestinal colic. Acta Vet Scand 1995 36 : 255 272.
60. Collatos C, Barton MH, Moore JN. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: changes associated with diagnosis, surgery, and outcome. J Vet Intern Med 1995 9 (1) : 18 23.
61. Welles EG, Prasse KW, Moore JN. Use of newly developed assays for protein C and plasminogen in horses with signs of colic. Am J Vet Res 1991 52 (2) : 345 351.
62. Prasse KW, Topper MJ, Moore JN, et al. Analysis of hemostasis in horses with colic. J Am Vet Med Assoc 1993 203 (5) : 685 693.
63. Armengou L, Monreal L, Tarancon I, et al. Plasma D-dimer concentrations in sick newborn foals. J Vet Intern Med 2008 22 : 411 417.
64. Weiss DJ, Trent AM, Johnston G. Prothrombotic events in the prodromal stages of acute laminitis. Am J Vet Res 1995 56 : 986 991.
65. Weiss DJ, Evanson OA, McClenahan D, et al. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res 1997 58 : 1376 1380.
66. Prasse KW, Allen D Jr., Moore JN, et al. Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses. Am J Vet Res 1990 51 : 1950 1955.
67. Bick R. Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemostas 1988 14 (4) : 299 338.
68. Wada H, Sakuragawa N, Mori Y, et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 1999 60 : 273 278.
69. Wada H. Pathophysiology and diagnostic criteria for disseminated intravascular coagulation associated with sepsis. Crit Care Med 2008 36 (1) : 348 349.
70. Van der Poll T, de Jonge E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemostasis 2001 27 (6) : 639 647.
71. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin N Am 2007 21 : 1 11.
72. Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008 36 : 145 150.
73. Toh CH, Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coag Fibrin 2005 16 : 69 74.
74. Pablo L, Purohit R, Teer P, et al. Disseminated intravascular strangulation obstruction in ponies. Am J Vet Res 1983 44 (1) : 2115 2122.
75. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007 82 (7) : 864 873.
76. Barton MH, Morris DD, Crowe N, et al. Hemostatic indices in healthy foals from birth to one month of age. J Vet Diagn Invest 1995 7 : 380 385.
77. Arkin CF, Adcock DM, Ernst DJ, et al. National Committee for Clinical Laboratory Standards. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays: Approved Guideline, 4th ed. Wayne, PA : NCCLS 2003 H21-A4.
78. De Boisblanc B. Venous thromboembolic disease, In : Internal Medicine Updates - 2003. Philadelphia, PA : American College of Physicians 2003, pp. 309 314.
79. Dallap Schaer BL, Wilkins PA, Boston R, et al. Preliminary evaluation of hemostasis in neonatal foals using a viscoelastic coagulation and platelet function analyzer. J Vet Emerg Crit Care 2009 19 (1) : 81 87.
80. Dallap Schaer BL, Bentz AI, Boston RC, et al. Comparison of viscoelastic coagulation analysis and standard coagulation profiles in critically ill neonatal foals to outcome. J Vet Emerg Crit Care 2009 19 (1) : 88 95.
81. Jesty J, Lorenz A, Rodriguez J, et al. Initiation of tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Blood 1996 15 : 2301 2307.
82. Opal S, Kessler CM, Roemisch J, et al. Antithrombin, heparin, and heparin sulfate. Crit Care Med 2002 30 (5) : S325 S331.
83. Eisele B, Lamy M, Thijs LG, et al. Antitrhombin III in patients with severe sepsis. A randomized placebo-controlled, double blind multicenter trial plus meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998 24 : 663 672.
84. Baudo F, Caimi TM, de Cataldo F, et al. Antithromvin III replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med 1998 24 : 336 342.
85. Warren BL, Eid A, Singer P, et al. KyberSept Trial Study Group. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001 286 : 1869 1878.
86. Dickneite G. Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost 1998 24 : 61 69.
87. Wiedermann CJ, Kaneider NC. A systematic review of antithrombin concentrate use inpatients with disseminated intravascular coagulation of severe sepsis. Blood Coagul Fibrinolysis 2006 17 : 521 526.
88. Holland M, Kelly A, Snyder J, et al. Antithrombin III activity in horses with large colon torsion. Am J Vet Res 1986 47 (4) : 897 900.
89. Pizzo S. Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. Am J Med 1989 87 (3) : B10S B14S.
90. Topper M, Prasse K, Morris M, et al. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses. Am J Vet Res 1996 57 (4) : 427 431.
91. Levi M., Keller TT, van Gorp E, et al. Infection and inflammation and the coagulation system. Cardiovas Res 2003 60 : 26 39.
92. Hancock WW., Tsuchida A, Hau H, et al. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc 1992 24 (5) : 2302 2303.
93. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 344 (10) : 699 709.
94. Hopper K, Bateman S. An updated view of hemostasis: mechanisms of hemostatic dysfunction associated with sepsis. J Vet Emerg Crit Care 2005 15 (2) : 83 91.
95. Barton MH, Moore JN, Fishcer JK. Influence of an ω-3 fatty acid-enriched ration on in vivo responses of horses to endotoxin. Am J Vet Res 1991 52 (4) : 523 527.
96. Barton MH, Moore JN, Norton N. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Am J Vet Res 1997 58 : 1300 1307.
97. Segura D, Monreal L, Armengou L, et al. Mean platelet component as an indicator of platelet activation in foals and adult horses. J Vet Intern Med 2007 21 : 1076 1082.
98. Macieira S, Rivard GE, Champagne J, et al. Glanzmann thrombasthenia in and Oldenbourg filly. Vet Clin Path 2007 36 : 204 208.
99. Norris JW, Pratt SM, Hunter JF, et al. Prevalence of reduced fibrinogen binding to platelets in a population of thoroughbreds. Am J Vet Res 2007 68 : 716 721.
100. Dunkel B, Rickards KJ, Page CP, et al. Platelet activation in ponies with airway inflammation. Equine Vet J 2007 39 (6) : 557 561.
101. Mateos-Trigos G, Evans RJ, Heath MF. Effects of P2Y1 and P2Y12 receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets. Platelets 2002 13 : 285 292.
102. Segura D, Monreal L, Perez-Pujol S, et al. Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques. J Vet Intern Med 2006 20 : 581 588.
103. Segura D, Monreal L. Poor reproducibility of template bleeding time in horses. J Vet Intern Med 2008 22 : 238 241.
104. Segura D, Monreal L, Espada Y, et al. Assessment of a platelet function analyser in horses: reference range and influence of a platelet aggregation inhibitor. Vet J 2005 170 : 108 112.
105. Schwarzwald CC, Feige K, Wunderli-Allenspach H, et al. Comparison of pharmacokinetic variables for two low-molecular-weight heparins after subcutaneous administration of a single dose to horses. Am J Vet Res 2002 63 : 868 873.
106. Cambridge H, Lees P, Hooke RE, et al. Antithrombotic actions of aspirin in the horse. Equine Vet J 1991 23 (2) : 123 127.
107. Lees P, Evans CP, Taylor JBO, et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone, and flunixin. Br Vet J 1983 143 : 462 476.
108. Feige K, Schwarzwald CC, Bombeli T. Comparison of unfractioned and low molecular weight heparin for prophylaxis of coagulopathies in 52 horses with colic: a randomised double-blind clinical trial. Equine Vet J 2003 35 (5) : 506 513.